Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT05136898 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Bladder Cancer
Urothelial Carcinoma
Urothelial Carcinoma Bladder

Interventions

DRUG: UGN-102

Sponsor

UroGen Pharma Ltd.